The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 24 articles
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Dubois C,
Dens J,
Farah B,
Carrié D,
Walsh S,
Oldroyd K,
Varenne O,
El-Jack S,
Moreno R,
Christen T,
Allocco D
April 20, 2018 | 10.4244/EIJ-D-17-00529
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I,
Dumonteil N,
Blackman D,
Tchetche D,
Walters D,
Hildick-Smith D,
Manoharan G,
Harnek J,
Worthley SG,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem N,
Feldman T,
Allocco D,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N,
Meredith I,
Blackman D,
Tchetche D,
Hildick-Smith D,
Spence M,
Walters D,
Harnek J,
Worthley SG,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem N,
Houle V,
Allocco D,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy
Kereiakes D,
Meredith I,
Masotti M,
Carrié D,
Moreno R,
Erglis A,
Mehta SR,
Elhadad S,
Berland J,
Stein B,
Airaksinen J,
Jobe R,
Reitman A,
Janssens L,
Christen T,
Dawkins K,
Windecker S
March 20, 2017 | 10.4244/EIJ-D-16-00643
Intravascular ultrasound guidance improves clinical outcomes during implantation of both first- and second-generation drug-eluting stents: a meta-analysis
Nerlekar N,
Cheshire C,
Verma K,
Ihdayhid A-R,
McCormick L,
Cameron J,
Bennett M,
Malaiapan Y,
Meredith I,
Brown A
January 20, 2017 | 10.4244/EIJ-D-16-00769
Intrepid transcatheter mitral valve replacement system: technical and product description
September 18, 2016 | 10.4244/EIJV12SYA21
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program
Abdel-Wahab M,
Neumann F,
Serruys P,
Silber S,
Leon M,
Mauri L,
Yeung A,
Belardi J,
Widimský P,
Meredith I,
Saito S,
Richardt G
July 20, 2016 | 10.4244/EIJY15M07_07
The Accucinch transcatheter direct mitral valve annuloplasty system
September 17, 2015 | 10.4244/EIJV11SWA16
A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial
Sakata K,
Koo B,
Waseda K,
Nakatani D,
Yock P,
Whitbourn R,
Worthley SG,
Ormiston J,
Webster M,
Wilkins G,
Honda Y,
Meredith I,
Fitzgerald P
March 20, 2015 | 10.4244/EIJY14M08_16
Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study
Sievert H,
Schofer J,
Ormiston J,
Hoppe U,
Meredith I,
Walters D,
Azizi M,
Diaz-Cartelle J,
Cohen-Mazor M
February 20, 2015 | 10.4244/EIJY14M12_01
Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
Serruys P,
Onuma Y,
Garcia-Garcia H,
Muramatsu T,
van Geuns R,
De Bruyne B,
Dudek D,
Thuesen L,
Smits P,
Chevalier B,
McClean D,
Koolen J,
Windecker S,
Whitbourn R,
Meredith I,
Dorange C,
Veldhof S,
Hebert K,
Rapoza R,
Ormiston J
March 20, 2014 | 10.4244/EIJV9I11A217
Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study
Buysschaert I,
Dubois C,
Dens J,
Ormiston J,
Worthley SG,
McClean D,
Ottervanger J,
Meredith I,
Uren N,
Wijns W,
Whitbourn R,
Mehran R,
Lansky A,
Bichalska M,
Meis S,
Verheye S
September 27, 2013 | 10.4244/EIJV9I5A93
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Weissman N,
Barragan P,
Scott D,
Valdés Chávarri M,
West N,
Kelbæk H,
Whitbourn R,
Walters D,
Kubica J,
Thuesen L,
Masotti M,
Banning AP,
Sjogren I,
Stables R,
Allocco D,
Dawkins K
July 26, 2013 | 10.4244/EIJV9I3A52
Boston Scientific Lotus valve
September 30, 2012 | 10.4244/EIJV8SQA12
Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials
Kereiakes D,
Popma J,
Cannon L,
Kandzari D,
Kimmelstiel C,
Meredith I,
Teirstein P,
Verheye S,
Allocco D,
Dawkins K,
Stone G
June 27, 2012 | 10.4244/EIJV8I2A32
First-in-human experience with the Medtronic Bifurcation Stent System
October 28, 2011 | 10.4244/EIJV7I6A108
PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses
Meredith I,
Whitbourn R,
Scott D,
El-Jack S,
Zambahari R,
Stone G,
Teirstein P,
Starzyk R,
Allocco D,
Dawkins K
May 17, 2011 | 10.4244/EIJV7I1A15
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023